Organigram Falls Despite Q3 Revenue Growth
The company disclosed third-quarter revenue of CA$24.75 million compared to $CA3.4 million in last year's quarter. This represented sales of around 3,926 kg of dried flower.
Organigram reported a quarterly net loss from continuing operations of CA$10.2 million or 7 cents per share on a diluted basis..
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — Click here to learn more!
Excluding the impact of non-cash fair value adjustments, the company’s third-quarter adjusted gross margin was $12.3 million or 50%, and year-to-date gross margin was $37.1 million or 58%.
“We continued to report strong sales in our third quarter and now have distribution in all ten provinces," said CEO Greg Engel. "While we saw a temporary reduction in yield per plant in Q3 due to temporary changes in growing protocols, not only have our yields returned to historical levels, but we have seen a meaningful increase in average cannabinoid levels in harvests to date in Q4."
OrganiGram's stock traded lower by 5.32% to $5.52 in Monday's pre-market session.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.